The best protection option designed spe-cifically for children! The three-in-one prism strengthens the constitution and promotes health improvement! 1. Patented two-layer encapsulation tech-nology ensure fixed-point releases, safe-guarding probiotics from destruction. 2. Added exclusive patent-protected probi-otics -patented LT12 probiotics 3. Growth-patented LABPRO compound probiotics 4. Promotes appetite, aids in digestion, and promotes synergistic absorption. 5. Facilitates defecation and alters the intes-tinal flora. 6. Contributes to the development of teeth and bones. 7. Xylitol helps maintain fresh breath.

D-Mannitol (sweetener), fructooligosaccharides, D-Sorbitol (sweetener), D-Xylitol (sweetener), microcrystalline α-Cellulose, polyvinylpyrrolidone, magnesium stearate, yogurt powder flavoring, silicon dioxide, lactic acid powder (Lactobacillus casei, Lactococcus lactis, Lactobacillus paracasei LT12, Lactobacillus acidophilus, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus rhamnosus, Lactobacillus plantarum, trehalose, corn starch), lactobacillus, colostrum powder, β-glucan.

Each tablet contains 1 billion CFU of probiotics.

Manufacturer Name: Hong Zhong Biotechnology Co., Ltd. Manufacturer Registration No.: 67003211 Manufacturer Quality Certifications: HACCP, ISO 22000

Raw material sampling and testing: appearance, moisture, total plate count, food additive license 2. Blending process sampling and testing: appearance, moisture, blending time, foreign matter 3. Tablet pressing project sampling and testing: hardness, weight, thickness,brittleness, moisture, appearance 4. Finished product sampling and testing: total plate count, E. coli, coliform bacteria, mold and yeast, bottle, fill quantity, imprinting and labeling.

SGS Testing Report: 812 Items

Tested Free from:

380 pesticide residues

5 heavy metals (including lead)

6 microbiological items

9 plasticizers

365 pharmaceutical substances

Water activity

8 colorants

11 preservatives

13 sweeteners

13 allergens

Raw material sampling and testing: appearance (complies with the manufacturer’s COA), moisture (complies with the manufacturer’s COA), total plate count (total viable count, E. coli, and coliform bacteria comply with the manufacturer’s COA), food additive license (complies with the food additive certificate). 2. Blending process sampling and testing: appearance (no foreign matter or impurities by visual inspection), moisture (≦8%), blending time (15 minutes for small blender, 20 minutes for large blender), foreign matter (magnetic rod inspection confirms no metal foreign substances). 3. Tablet pressing sampling and testing: hardness (confirmed by hardness tester according to tablet formulation standard), weight (confirmed by electronic balance according to tablet formulation standard), thickness (confirmed by caliper according to tablet formulation standard), brittleness (<0.60%), moisture (≦8%), appearance (no broken tablets). 4. Finished product sampling and testing: total plate count (<1×10⁴ CFU/g), E. coli (<1×10² CFU/g), coliform bacteria (Negative), mold and yeast (<1×10² CFU/g), bottle (contains desiccant, liner, securely locked cap, clean, free from foreign matter or damage), fill quantity (complies with label and customer requirements), imprinting (clear font, correct position and content), and labeling (batch number, expiry date, and imprinting are correct and intact).

Lactobacillus paracasei LT12 CN102168043A、EP2338977B1、JP2011142907A、KR101504373B1、US8372392B2、TWI418356B：Lactobacillus paracasei strain LT12 as immunity regulatory agent ◆ colostrum powder (USA) US20050092684、US20050092684A1：Novel colostral fractionation process ◆ LAB2PRO-Lactobacillus casei, Lactobacillus, acidophilus, Bifidobacteriumlongum, Bifidobacterium lactis, Lactobacillus rhamnosus, Lactobacillus plantarum 1. KR20010010397A、EP1514553B1、JP3720780B2、US20040247580A1、ZL20120262911.2：Zweifach Coating-beschichteten Milchsäurenbakterienpulver mit Protein und Polysaccharid und das Verfahren zur deren Herstellung sowie deren Dosisform 2. KR101473146B1：Composition for preventing or treating irritable bowel syndrome 3. KR101611834B1、KR101611837B1：Use of lactobacillus plantarum cbt lp3 in the prevention or treatment of obesity and obesity-related metabolic syndrome and composition comprising the same 4. KR101724601B1：Composition for preventing or treating atopic dermatitis 5. KR101279852B1：Composition for preventing or treating osteoporosis comprising multi-species pobiotic mixture 6. KR101228035B1：New lactobacillus strains and compositions for preventing or treating diabetes comprising the same 7. KR101589466B1：Use of bifidobacterium longum cbt bg7 strain for promoting growth and nutraceutical composition for promoting growth comprising the same 8. KR101656208B1：omposition for use in the prevention or treatment of inflammatory disease